Microviable Therapeutics was selected to present at Anglonordic Life Science Conference 2023, taking place on April 20th in London. Exclusively selected attendees will represent the key drivers of the European life sciences growth sector. Microviable's [...]
Our new research article: “GutAlive® enables DNA-based microbiome analysis without disrupting the original composition and diversity” A precise faecal microbiome analysis requires normalized methods for microbiome sampling, transport and manipulation in order to obtain [...]
Microviable Therapeutics announced the appointment of Dr. Luis Gosálbez as a member of its Business Advisory Board. Gosálbez brings 10 years of experience in business strategy and corporate development for life sciences companies specialized in [...]
Microviable Therapeutics will be presenting at XIV Workshop of SEMiPYP (Spanish Society of Microbiota, Probiotics and Prebiotics) taking place on March 8th-10th at Pamplona. Claudio Hidalgo, CEO at Microviable, Noelia Martínez, R&D Director, and Ignacio [...]
Microviable Therapeutics will be attending the XIV Workshop of SEMiPYP (Spanish Society of Microbiota, Probiotics and Prebiotics) taking place on March 8th-10th at Pamplona. The event will make special mention of the new advances in [...]
Microviable welcomes to the team our new internship student José González Poyo, Master in Environmental and Health Biotechnology from the University of Oviedo.
We are looking for a full-time, highly motivated individual to work as a bioinformatician in our team to develop prediction models using artificial intelligence for novel biotherapeutics development. More information If you are interested [...]
From Microviable in the International Day of Women and Girls in Science, we want to speakup for all the female working in STEM (Science, Technology, Engineering and Mathematics), not only for their great work but [...]
Microviable Therapeutics is looking for a full-time, highly motivated individual to work as a Quality Assurance CMO specialist with cGMP experience for novel biotherapeutic products. More information If you are interested in working with [...]
The European Medicines Agency (EMA) granted the qualification of “Small and Medium-Sized Enterprises” (SME) to Microviable Therapeutics. The European Medicines Agency (EMA) provides incentives and support for micro, small and medium-sized enterprises (SMEs) that are [...]